España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Synchron
Neuralink Rival Backed By Jeff Bezos And Bill Gates Broadens Horizons With Plans To Treat Parkinson's, Epilepsy
Jeff Bezos, Bill Gates-Backed Synchron Set To Challenge Elon Musk's Neuralink With Upcoming Large-Scale Brain Implant Trial
Elon Musk's Neuralink Is 'Heading' For Human Trials As Brain Computer Interface Startup Receives FDA Approval
Jeff Bezos, Bill Gates-Backed Synchron Set To Challenge Elon Musk's Neuralink With Upcoming Large-Scale Brain Implant Trial
Elon Musk's Neuralink Is 'Heading' For Human Trials As Brain Computer Interface Startup Receives FDA Approval
It's Alive? Billionaire Li Ka-Shing Funds Startup Growing Brain Cell 'Biocomputers'
Bezos- And Gates-Backed Brain Implant Startup Conducts Mind-Controlled Computing Trials On Humans
It's Alive? Billionaire Li Ka-Shing Funds Startup Growing Brain Cell 'Biocomputers'
Bezos- And Gates-Backed Brain Implant Startup Conducts Mind-Controlled Computing Trials On Humans
The Rise Of Neurotechnology: Neuroscientist-Developed Wearable Promises Stress Relief, Sharper Focus, and Unprecedented Calm
Elon Musk Says Neuralink Is The Only Way To Survive And Compete With AI
Read More...
Synchron Recent News
Bill Gates, Jeff Bezos Make Big Bets On Neuralink Rival — But Is Elon Musk Worried?
As Elon Musk's Neuralink surrounds itself with controversies and a federal investigation, Bill Gates and Jeff Bezos are backing one of its key
Elon Musk's Brain-Chip Company Neuralink Gets Overtaken In US By Australian Startup
Australia-based startup Synchron planted its fifth brain-computer device and the first into the brain of a U.S.